AssayIndex
Reports by quarter

Reports submitted in 2024-Q3 · page 3

Nordanalyt Laboratories began contributing. Median purity for the quarter is 99.07 % area, n=464. Read the 2024-Q3 state-of-the-index report →

464 records12 pagesmedian on this page 99.13 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2024-005300TirzepatideBCHBCH-2404-N5218Janoshik2024-Q397.733.35102.9Buyer-sourced0PASS
AX-2024-004694GHK-CuHomopeptideHOMO-2408-C3445Janoshik2024-Q399.195.69—Buyer-sourced0PASS
AX-2024-004379L-Glutathione (reduced)FGPFGP-2405-E9260VendorInvestigate2024-Q399.686.11100.3Buyer-sourced0PASS
AX-2024-004365SermorelinFGPFGP-2406-D8645Janoshik2024-Q399.593.0498.0Buyer-sourced1MARGINAL
AX-2024-005362MK-677 (Ibutamoren mesylate)SIGSIG-2404-6898VendorInvestigate2024-Q399.003.8797.2Buyer-sourced1FAIL
AX-2024-005210TirzepatideWXTWXT-2402-B2476Janoshik2024-Q399.142.66—Buyer-sourced0PASS
AX-2024-004227LiraglutideWWBWWB-2406-R3462Medutest2024-Q399.352.4693.3Buyer-sourced0PASS
AX-2024-005320NAD+QSTQST-2402-B5599Kestrel2024-Q398.068.5290.6Buyer-sourced0PASS
AX-2024-005112SemaxGL BiochemGLBI-2404-U8284Janoshik2024-Q399.137.9389.8Buyer-sourced2MARGINAL
AX-2024-004708OxytocinHomopeptideHOMO-2405-U3389Janoshik2024-Q399.935.7490.4Buyer-sourced1FAIL
AX-2024-004697GHK-CuHomopeptideHOMO-2408-C3445Janoshik2024-Q398.934.85102.8Buyer-sourced0PASS
AX-2024-004539HexarelinHYBHYB-2407-N7367VendorInvestigate2024-Q399.884.99—Buyer-sourced0PASS
AX-2024-004134RetatrutideWWBWWB-2405-W1240Medutest2024-Q398.542.6598.6Buyer-sourced1MARGINAL
AX-2024-005379AOD-9604PPGPPG-2408-T7905PeptideMeter2024-Q399.361.84—Buyer-sourced0PASS
AX-2024-005269VIPBCHBCH-2405-R4888Janoshik2024-Q397.345.2799.6Buyer-sourced0FAIL
AX-2024-004993TirzepatideKPKP-2407-T4788Janoshik2024-Q397.575.0596.3Buyer-sourced0PASS
AX-2024-004701GHK-CuHomopeptideHOMO-2408-C3445Janoshik2024-Q398.835.0288.7Buyer-sourced1MARGINAL
AX-2024-004217LiraglutideWWBWWB-2406-R3462Janoshik2024-Q399.282.58101.4Laboratory-retained1FAIL
AX-2024-004583SemaglutideJEEPJEEP-2403-V9444Janoshik2024-Q399.371.53—Laboratory-retained0PASS
AX-2024-004523ARA-290HYBHYB-2403-B7301Kestrel2024-Q399.667.43—Buyer-sourced0PASS
AX-2024-004375L-Glutathione (reduced)FGPFGP-2405-E9260Janoshik2024-Q399.615.8491.0Buyer-sourced0PASS
AX-2024-004261TirzepatideQYBQYB-2403-T4551Janoshik2024-Q399.304.69—Laboratory-retained0PASS
AX-2024-004216LiraglutideWWBWWB-2406-R3462VendorInvestigate2024-Q399.071.3497.3Buyer-sourced0PASS
AX-2024-005021IGF-1 LR3KPKP-2406-K5300Janoshik2024-Q398.076.75101.0Buyer-sourced0PASS
AX-2024-004601Enclomiphene citrateTFCTFC-2404-J9626Janoshik2024-Q399.543.74—Supplier-supplied0FAIL
AX-2024-004527ARA-290HYBHYB-2403-B7301PeptideMeter2024-Q399.347.49103.7Buyer-sourced0PASS
AX-2024-004378L-Glutathione (reduced)FGPFGP-2405-E9260Janoshik2024-Q399.645.7993.1Buyer-sourced0PASS
AX-2024-004259TirzepatideQYBQYB-2403-T4551Janoshik2024-Q399.285.55—Buyer-sourced0PASS
AX-2024-005357MK-677 (Ibutamoren mesylate)SIGSIG-2404-6898Janoshik2024-Q399.093.3691.8Laboratory-retained0FAIL
AX-2024-005266VIPBCHBCH-2405-R4888Janoshik2024-Q397.434.81—Supplier-supplied0FAIL
AX-2024-005013SemaglutideKPKP-2405-C4939Janoshik2024-Q397.665.3797.6Buyer-sourced0PASS
AX-2024-004888GHRP-6ERPERP-2408-R9378Janoshik2024-Q398.714.8896.3Buyer-sourced1FAIL
AX-2024-004335EpitalonQSCQSC-2403-Y7501Janoshik2024-Q399.935.99—Buyer-sourced1MARGINAL
AX-2024-005215TirzepatideWXTWXT-2402-B2476Janoshik2024-Q399.122.90—Buyer-sourced0PASS
AX-2024-005091GlucagonSSASSA-2408-F7321Janoshik2024-Q398.537.6098.6Buyer-sourced0PASS
AX-2024-005071SS-31 (Elamipretide)SSASSA-2408-G7111Medutest2024-Q397.166.27—Buyer-sourced0FAIL
AX-2024-004877TirzepatideERPERP-2406-E9182PeptideMeter2024-Q397.964.27—Laboratory-retained0PASS
AX-2024-004705GHK-CuHomopeptideHOMO-2408-C3445Janoshik2024-Q399.054.87—Buyer-sourced0PASS
AX-2024-004596Enclomiphene citrateTFCTFC-2404-J9626VendorInvestigate2024-Q399.833.3691.5Buyer-sourced1FAIL
AX-2024-004372L-Glutathione (reduced)FGPFGP-2405-E9260Janoshik2024-Q399.466.3195.0Buyer-sourced0PASS